 |
|
|
|
|
|
|
Tolazamide
Tolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes. It is part of the sulfonamide family (ATC A10BB).
| Oral antidiabetic drugs and Insulin analogs (A10) |
|---|
| Biguanides | Metformin |
|---|
| Sulfonylureas | Chlorpropamide, Glibenclamide (Glyburide), Gliclazide, Glimepiride, Glipizide, Gliquidone, Tolazamide, Tolbutamide |
|---|
| Alpha-glucosidase inhibitors | Acarbose, Miglitol, Voglibose |
|---|
| Thiazolidinediones (TZD) | Pioglitazone, Rosiglitazone, Troglitazone |
|---|
| Meglitinides | Nateglinide, Repaglinide, Mitiglinide |
|---|
| Dipeptidyl peptidase-4 (DPP-4) inhibitors | Saxagliptin, Sitagliptin, Vildagliptin |
|---|
| Glucagon-like peptide-1 analog | Exenatide |
|---|
| Insulin analogs | fast acting (Insulin lispro, Insulin aspart, Insulin glulisine), intermediate-acting (NPH insulin), long acting (Insulin glargine, Insulin detemir) |
|---|
|
| |
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Tolazamide". A list of authors is available in Wikipedia.
|
|
|
|
|
|
Top